204 related articles for article (PubMed ID: 1291421)
41. Long-term survival of patients with chest pain syndrome and angiographically normal or near-normal coronary arteries: the additional prognostic value of dipyridamole echocardiography test (DET).
Sicari R; Palinkas A; Pasanisi EG; Venneri L; Picano E
Eur Heart J; 2005 Oct; 26(20):2136-41. PubMed ID: 16014645
[TBL] [Abstract][Full Text] [Related]
42. Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value.
Chiarella F; Domenicucci S; Bellotti P; Bellone P; Scarsi G; Vecchio C
Eur Heart J; 1994 Jun; 15(6):842-50. PubMed ID: 8088274
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups.
Pingitore A; Picano E; Varga A; Gigli G; Cortigiani L; Previtali M; Minardi G; Colosso MQ; Lowenstein J; Mathias W; Landi P
J Am Coll Cardiol; 1999 Nov; 34(6):1769-77. PubMed ID: 10577568
[TBL] [Abstract][Full Text] [Related]
44. Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography. Comparison with positron emission tomography and quantitative arteriography.
Picano E; Parodi O; Lattanzi F; Sambuceti G; Andrade MJ; Marzullo P; Giorgetti A; Salvadori P; Marzilli M; Distante A
Circulation; 1994 Feb; 89(2):753-61. PubMed ID: 8313564
[TBL] [Abstract][Full Text] [Related]
45. Dipyridamole stress echocardiography in patients with severe left main coronary artery narrowing. Echo Persantine International Cooperative (EPIC) Study Group--Subproject "Left Main Detection".
Andrade MJ; Picano E; Pingitore A; Petix N; Mazzoni V; Landi P; Raciti M
Am J Cardiol; 1994 Mar; 73(7):450-5. PubMed ID: 8141085
[TBL] [Abstract][Full Text] [Related]
46. [Thallium and echo- dipyridamole in the early selection of patients at risk after acute myocardial infarction. Which test? What dose?].
Casanova R; Fabbri M; Patroncini A; Jacopi F; Pirazzini L; Varani E; Maresta A
G Ital Cardiol; 1991 Apr; 21(4):377-86. PubMed ID: 1936742
[TBL] [Abstract][Full Text] [Related]
47. Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting.
Cortigiani L; Picano E; Coletta C; Chiarella F; Mathias W; Gandolfo N; De Alcantara M; Mazzoni V; Gensini GF; Landi P; ;
Am Heart J; 2001 Apr; 141(4):621-9. PubMed ID: 11275930
[TBL] [Abstract][Full Text] [Related]
48. Usefulness of dipyridamole-echocardiographic test to identify jeopardized myocardium after thrombolysis. Limited clinical predictivity of dipyridamole-echocardiographic test in convalescing acute myocardial infarction: correlation with coronary angiography.
Sclavo MG; Noussan P; Pallisco O; Presbitero P
Eur Heart J; 1992 Oct; 13(10):1348-55. PubMed ID: 1396807
[TBL] [Abstract][Full Text] [Related]
49. [Aspects of risk stratification in acute coronary syndrome (Part II): Prognostic value of evaluation of exercise-induced myocardial ischemia according to the data of pharmacological stress echocardiography].
Gukasian VA; Matskeplishvili ST; Ioshina VI; Aripov MA; Shakhnazarian LS; Asymbekova ÉU; Zhertovskaia EV; Buziashvili IuI
Ter Arkh; 2012; 84(12):23-9. PubMed ID: 23479984
[TBL] [Abstract][Full Text] [Related]
50. The value of dipyridamole echocardiography in risk stratification before vascular surgery. A multicenter study. The EPIC (Echo Persantine International Study) Group--Subproject: Risk Stratification Before Major Vascular Surgery.
Sicari R; Picano E; Lusa AM; Salustri A; Ciavatti M; Del Rosso G; Kozakova M; Ferrari M; Pedrinelli R; Pingitore A
Eur Heart J; 1995 Jun; 16(6):842-7. PubMed ID: 7588929
[TBL] [Abstract][Full Text] [Related]
51. Dipyridamole echocardiography test. A new tool for detecting jeopardized myocardium after thrombolytic therapy.
Bolognese L; Sarasso G; Bongo AS; Rossi L; Aralda D; Piccinino C; Rossi P
Circulation; 1991 Sep; 84(3):1100-6. PubMed ID: 1884442
[TBL] [Abstract][Full Text] [Related]
52. Prognostic importance of dipyridamole-echocardiography test in coronary artery disease.
Picano E; Severi S; Michelassi C; Lattanzi F; Masini M; Orsini E; Distante A; L'Abbate A
Circulation; 1989 Sep; 80(3):450-7. PubMed ID: 2766502
[TBL] [Abstract][Full Text] [Related]
53. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain.
Cortigiani L; Paolini EA; Nannini E
Circulation; 1998 Dec 22-29; 98(25):2855-9. PubMed ID: 9860787
[TBL] [Abstract][Full Text] [Related]
54. Multicenter trial on prognostic value of inducible ischemia, assessed by dobutamine stress echocardiography and exercise electrocardiography test, in patients with uncomplicated myocardial infarction, treated with thrombolytic therapy.
Galati A; Bigi R; Coletta C; Fiorentini C; Ricci R; Occhi G; Sestili A; Rulli F; Aspromonte N; Fera MS; Greco G; Guagnozzi G; Ceci V
Int J Card Imaging; 1998 Jun; 14(3):155-62. PubMed ID: 9813751
[TBL] [Abstract][Full Text] [Related]
55. The atropine factor in pharmacologic stress echocardiography. Echo Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups.
Pingitore A; Picano E; Colosso MQ; Reisenhofer B; Gigli G; Lucarini AR; Petix N; Previtali M; Bigi R; Chiarandà G; Minardi G; de Alcantara M; Lowenstein J; Sclavo MG; Palmieri C; Galati A; Seveso G; Heyman J; Mathias W; Casazza F; Sicari R; Raciti M; Landi P; Marzilli M
J Am Coll Cardiol; 1996 Apr; 27(5):1164-70. PubMed ID: 8609337
[TBL] [Abstract][Full Text] [Related]
56. Clinical, resting echo and dipyridamole stress echocardiography findings for the screening of renal transplant candidates.
Cortigiani L; Desideri A; Gigli G; Vallebona A; Terlizzi R; Giusti R; Rossi B; Solari P; Antonelli A; Bigi R
Int J Cardiol; 2005 Aug; 103(2):168-74. PubMed ID: 16080976
[TBL] [Abstract][Full Text] [Related]
57. [Prognostic stratification after acute uncomplicated myocardial infarction: exercise test, echo-dobutamine test or both?].
Greco CA; Salustri A; Biferali F; Ciavatti M; Trocino G; Seccareccia F; Valtorta C; Guzzardi G; Falcone M; Schiavina R; Palamara A
G Ital Cardiol; 1997 May; 27(5):450-7. PubMed ID: 9244750
[TBL] [Abstract][Full Text] [Related]
58. The prognostic value of Doppler echocardiographic-derived coronary flow reserve is not affected by concomitant antiischemic therapy at the time of testing.
Sicari R; Rigo F; Gherardi S; Galderisi M; Cortigiani L; Picano E
Am Heart J; 2008 Sep; 156(3):573-9. PubMed ID: 18760143
[TBL] [Abstract][Full Text] [Related]
59. Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Echo Persantine Italian Cooperative (EPIC) Study Group, Subproject Hypertrophic Cardiomyopathy.
Lazzeroni E; Picano E; Morozzi L; Maurizio AR; Palma G; Ceriati R; Iori E; Barilli A
Circulation; 1997 Dec; 96(12):4268-72. PubMed ID: 9416892
[TBL] [Abstract][Full Text] [Related]
60. Early post-infarction angina: usefulness of dipyridamole-echocardiography test.
Picano E; Lattanzi F; Masini M; Distante A; L'Abbate A
Eur Heart J; 1986 Dec; 7 Suppl C():55-8. PubMed ID: 3816831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
